<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xia Y</submitter><funding>National Natural Science Foundation of China</funding><funding>China Postdoctoral Science Foundation</funding><pagination>71</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6849323</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Previous studies have reported that tea extract supplementation has potential benefits on the risk factors of non-alcoholic fatty liver disease (NAFLD); however, no study has investigated the direct effect of daily tea consumption on the prevalence of NAFLD in the general population. This cross-sectional study aimed to evaluate the associations between tea consumption and the prevalence of newly diagnosed NAFLD among Chinese adults.&lt;h4>Methods&lt;/h4>The present cross-sectional study was based on the Tianjin Chronic Low-grade Systemic Inflammation and Health Cohort Study. In total, 19,350 participants were enrolled in the analyses. Tea consumption was assessed via a self-administered food frequency questionnaire. NAFLD was diagnosed via liver ultrasonography and no history </pubmed_abstract><journal>Nutrition journal</journal><pubmed_title>Daily tea drinking is not associated with newly diagnosed non-alcoholic fatty liver disease in Chinese adults: the Tianjin chronic low-grade systemic inflammation and health cohort study.</pubmed_title><pmcid>PMC6849323</pmcid><funding_grant_id>81903302</funding_grant_id><funding_grant_id>91746205</funding_grant_id><funding_grant_id>2018M641753</funding_grant_id><funding_grant_id>81673166</funding_grant_id><pubmed_authors>Xia Y</pubmed_authors><pubmed_authors>Zhou M</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Gu Y</pubmed_authors><pubmed_authors>Wu Q</pubmed_authors><pubmed_authors>Bao X</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Wu H</pubmed_authors><pubmed_authors>Jia Q</pubmed_authors><pubmed_authors>Song K</pubmed_authors><pubmed_authors>Sun S</pubmed_authors><pubmed_authors>Niu K</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Meng G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Daily tea drinking is not associated with newly diagnosed non-alcoholic fatty liver disease in Chinese adults: the Tianjin chronic low-grade systemic inflammation and health cohort study.</name><description>&lt;h4>Background&lt;/h4>Previous studies have reported that tea extract supplementation has potential benefits on the risk factors of non-alcoholic fatty liver disease (NAFLD); however, no study has investigated the direct effect of daily tea consumption on the prevalence of NAFLD in the general population. This cross-sectional study aimed to evaluate the associations between tea consumption and the prevalence of newly diagnosed NAFLD among Chinese adults.&lt;h4>Methods&lt;/h4>The present cross-sectional study was based on the Tianjin Chronic Low-grade Systemic Inflammation and Health Cohort Study. In total, 19,350 participants were enrolled in the analyses. Tea consumption was assessed via a self-administered food frequency questionnaire. NAFLD was diagnosed via liver ultrasonography and no history </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Nov</publication><modification>2025-04-18T23:39:32.933Z</modification><creation>2020-05-21T18:47:21Z</creation></dates><accession>S-EPMC6849323</accession><cross_references><pubmed>31711498</pubmed><doi>10.1186/s12937-019-0502-y</doi></cross_references></HashMap>